Pfizer, Inc. · NYSE:PFE
Pfizer — Bernstein Pharmaceutical Emerging Markets Conference 2009
21 slides from Pfizer's conference presentation, May 6, 2009
Slide 1: Pfizer Emerging Markets
Pfizer Emerging Markets Jean-Michel Halfon President and General Manager May 6, 2009
Slide 2: Forward-Looking Statements and Non-GAAP Financial Information
Forward-Looking Statements and Non-GAAP Financial Information Our discussions during this presentation will include forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are dis
Slide 3: Overview
Overview • Introduction to Pfizer Emerging Markets • Strategic Priorities • Focus on Priority Markets 2
Slide 4: Pfizer Emerging Markets: Who We Are
Pfizer Emerging Markets: Who We Are 16,000 colleagues More than 70 countries Across 20 time zones Approximately 5 billion people 3
Slide 5: Our Vision and Mission
Our Vision and Mission We will be recognized for meeting the diverse medical Vision needs of patients in Emerging Markets around the world in an innovative, socially responsible and commercially viable manner. We will… develop bold and innovative partnerships Mission reach patients we have never rea
Slide 6: Pfizer's Global Footprint Supports Growth in EMs
Pfizer’s Global Footprint Supports Growth in EMs Established, well-known brand in EMs Commitment to dedicate significant resources Global research and manufacturing capabilities Capitalizing on the power of scale 5
Slide 7: New Business Model Actively Addresses Key Capabilities
New Business Model Actively Addresses Key Capabilities Previous Model New Model: Pfizer Emerging Markets Governance EM grouped with developed • One leadership team with 100% focus on EM • Strong local presence markets • Maintain high engagement Business Needs not well understood or • Clear process w
Slide 8: Established Commercial Model Builds Local Capabilities
Established Commercial Model Builds Local Capabilities Global Enterprise Local Ecosystem Global processes Local processes Global talent Local talent Global resources Local resources Global Hub Adapted from Gupta, Anil K. & Wang, Haiyan: Getting China and India Right: Strategies for Leveraging the Wo
Slide 9: Pfizer Emerging Markets Current Performance
Pfizer Emerging Markets Current Performance Q1 Revenues (US $ Billions) 5% growth* *Q1 2009 Operational Growth 8
Slide 10: Our Strategic Priorities
Our Strategic Priorities 1 Drive incremental organic growth 2 Pursue strategic acquisitions / partnerships 3 Seek game-changing opportunities for innovation 9
Slide 11: Drive Incremental Organic Growth
1 Drive Incremental Organic Growth Focus on core brands and new product launches Prioritize Oncology Development: as a major growth • 22 NMEs • 10 Phase 3 trials driver Optimize MEDROL Expanding geographic reach and customer base Established E-card program: Products revenues 10
Slide 12: Pursue Strategic Acquisitions/Partnerships: Wyeth
2 Pursue Strategic Acquisitions/Partnerships Wyeth diversifies offering and expands presence in EMs Biopharmaceuticals • Primary Care • Specialty Care Pharmaceuticals – Vaccines – Biologics • Primary Care • Oncology • Specialty Care • Established Products • Oncology • Established Products Diversifie
Slide 13: Pursue Strategic Acquisitions/Partnerships: Execution and Implementation
2 Pursue Strategic Acquisitions/Partnerships Execution and Implementation Negotiations and Recommendation Analysis and Due Diligence Strategy Alignment Idea Generation 12
Slide 14: Seek Game-Changing Opportunities for Innovation: Global Access Strategy
3 Seek Game-Changing Opportunities for Innovation Global Access Strategy • Commercially viable • Sustainable • Socially responsible New Access to R&D for Healthcare Key Account Commercial Innovative Unmet Medical Financing Management Models Products Needs 13
Slide 15: Seek Game-Changing Opportunities for Innovation
3 Seek Game-Changing Opportunities for Innovation 14
Slide 16: Focus on Priority Markets
Focus on Priority Markets Russia Turkey Mexico China India Brazil 15
Slide 17: Geographic Expansion in China
Geographic Expansion in China 2009: 177 cities with 2,300 reps 2011: 252 cities with 3,200 reps Dalian Manufacturing Shanghai Research hub = 100 reps 16
Slide 18: Private-Sector Involvement in India
Private-Sector Involvement in India Growing research • Preferred Research Centres to build research capacity and education • Pfizer Education and Research League training programs Supporting public • Partnering with leading healthcare provider • Opening 600 smoking cessation clinics health initiativ
Slide 19: Focus on Public-Private Partnerships in Turkey
Focus on Public-Private Partnerships in Turkey Research and • Partnership with Hacettepe University • Creation of government-supported technoparks development • Supports ongoing collaboration between academia and private sector • Designated as Key Strategic Site – driving excellence in clinical tria
Slide 20: Meeting our Goals for Growth
Meeting our Goals for Growth • Driving growth in our six priority markets • Optimizing revenues for Established Products • Concentrating on key therapeutic areas, including Oncology 19
Slide 21: Pfizer Emerging Markets
Pfizer Emerging Markets Jean-Michel Halfon President and General Manager May 6, 2009
Pfizer — Bernstein Pharmaceutical Emerging Markets Conference 2009 on 6ix